[ 鐧诲綍] [ 鍏嶈垂娉ㄥ唽]
璇曞墏浠櫒缃? title=
浣嶇疆锛欬a href="//www.vuestras.com/sigma-aldrich/">棣栭〉> 鍝佺墝> Sigma-Aldrich> PAX-8 Rabbit Polyclonal Antibody

PAX-8 Rabbit Polyclonal Antibody

鍝佺墝
Sigma-Aldrich
璐у彿
363A-1
鍖呰鍨嬪彿
瑙勬牸绾害
鍙傝€冧环鏍稽/div>
3531.56 鍏傸/span>*鏈环鏍煎惈澧炲€肩◣璐更/span>
淇冮攢
鏈嶅姟
  • 鈭欬/span>鍘熷巶淇濊瘉
  • 鈭欬/span>鍖呴偖
  • 鈭欬/span>澧炲€肩◣绁?/li>
鏁伴噺
- +
浜у搧鍚嶇О锛欬/div>
PAX-8 Rabbit Polyclonal Antibody
浜у搧浠嬬粛锛欬/div>

浜у搧璇存槑

涓€鑸弿杩?/p>

This protein is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically encode proteins which contain a paired box domain, an octapeptide, and a paired-type homeodomain. This nuclear protein is involved in thyroid follicular cell development and expression of thyroid-specific genes. Mutations in this gene have been associated with thyroid dysgenesis, thyroid follicular carcinomas and atypical thyroid adenomas. PAX-8 is expressed in the thyroid (and associated carcinomas), non-ciliated mucosal cells of the fallopian tubes and simple ovarian inclusion cysts, but not normal ovarian surface epithelial cells. PAX-8 is expressed in a high percentage of ovarian serous, endometrioid, and clear cell carcinomas, but only rarely in primary ovarian mucinous adenocarcinomas. Studies have also found PAX-8 experession in renal tubules as well as renal carcinoma, nephroblastoma and seminoma. Most recently a study by Tong et al. showed that 98% of clear cell RCCs, 90% of papillary RCCs, and 95% of oncocytomas were positive for PAX-8, frequencies which are similar or better than for PAX-2. Therefore, PAX-8 may be used as an additional immunohistochemical marker for renal epithelial tumors. Normal lung and lung carcinomas do not express PAX-8. Similarly, the absence of expression of PAX-8 in breast and other non-GYN carcinomas other than those primary to the thyroid indicates that PAX-8 is an important new marker of ovarian cancer and a useful marker for the differential diagnoses in lung and neck tumors, or tumors at distant sites where primary lung carcinoma or thyroid carcinoma are possibilities. PAX-8, combined with organ system-specific markers such as uroplakin, mammaglobin, and TTF-1 can be a very useful panel to determine the primary site of invasive micropapillary carcinomas of ovary, bladder, lung, or breast.

璐ㄩ噺


IVD

IVD

IVD

RUO

澶栧舰

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

鍏朵粬璇存槑

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

娉曞緥淇℃伅

Cell Marque is a trademark of sigma-aldrich Co. LLC

鍩烘湰淇℃伅

NACRES NA.41

浜у搧鎬ц川

鐢熺墿鏉ユ簮 rabbit
璐ㄩ噺姘村钩 500
100
鍋惰仈鐗?/td> unconjugated
鎶椾綋褰㈠紡 Ig fraction of antiserum
antibody product type primary antibodies
鍏嬮殕 polyclonal
鎻忚堪 For In Vitro Diagnostic Use in Select Regions (See Chart)
褰㈠紡 buffered aqueous solution
species reactivity human
鍖呰 vial of 0.1 mL concentrate (363A-14)
vial of 0.5 mL concentrate (363A-15)
bottle of 1.0 mL predilute (363A-17)
bottle of 7.0 mL predilute (363A-18)
manufacturer/tradename Cell Marque?
technique(s) immunohistochemistry: 1:25-1:100
杩愯緭 wet ice
鍌ㄥ瓨娓╁害 2-8鈩傸/td>

瀹夊叏淇℃伅

鍌ㄥ瓨鍒嗙被浠g爜 12 - Non Combustible Liquids
WGK WGK 2
闂偣(F) Not applicable
闂偣(C) Not applicable

Sigma-Aldrich

鎺ㄨ崘浜у搧
Baidu
map